Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Multiple sclerosis in the UK: service use, costs, quality of life and disability.

McCrone P, Heslin M, Knapp M, Bull P, Thompson A.

Pharmacoeconomics. 2008;26(10):847-60. Erratum in: Pharmacoeconomics. 2009;27(4):354.

PMID:
18793032
2.

Costs and quality of life of multiple sclerosis in Austria.

Kobelt G, Berg J, Lindgren P, Plesnilla C, Baumhackl U, Berger T, Kolleger H, Vass K.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S14-23.

PMID:
17310339
3.

Costs and quality of life of multiple sclerosis in the United Kingdom.

Kobelt G, Berg J, Lindgren P, Kerrigan J, Russell N, Nixon R.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104.

PMID:
17310341
4.

Costs and quality of life of multiple sclerosis in Sweden.

Berg J, Lindgren P, Fredrikson S, Kobelt G.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S75-85.

PMID:
17310342
5.

Costs and quality of life of multiple sclerosis in Switzerland.

Kobelt G, Berg J, Lindgren P, Gerfin A, Lutz J.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S86-95.

PMID:
17310338
6.

Costs and quality of life for patients with multiple sclerosis in Belgium.

Kobelt G.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S24-33.

PMID:
17318662
7.

Costs and quality of life of multiple sclerosis in Italy.

Kobelt G, Berg J, Lindgren P, Battaglia M, Lucioni C, Uccelli A.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S45-54.

PMID:
17310336
8.

Costs and quality of life of multiple sclerosis in Germany.

Kobelt G, Berg J, Lindgren P, Elias WG, Flachenecker P, Freidel M, König N, Limmroth V, Straube E.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S34-44.

PMID:
17310337
9.

Costs and quality of life in multiple sclerosis in The Netherlands.

Kobelt G, Berg J, Lindgren P, Anten B, Ekman M, Jongen PJ, Polman C, Uitdehaag B.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S55-64. Erratum in: Eur J Health Econ. 2007 Dec;8(4):359. Anten, Bert [added]; Ekman, Mattias [added]; Jongen, Peter J H [added]; Polman, Chris [added]; Uitdehaag, Bernard [added].

PMID:
17310343
10.

Costs and quality of life of multiple sclerosis in Spain.

Kobelt G, Berg J, Lindgren P, Izquierdo G, Sánchez-Soliño O, Pérez-Miranda J, Casado MA; Associación Española de Esclerosis Múltiple.

Eur J Health Econ. 2006 Sep;7 Suppl 2:S65-74.

PMID:
17310340
11.

Burden of a multiple sclerosis relapse: the patient's perspective.

Oleen-Burkey M, Castelli-Haley J, Lage MJ, Johnson KP.

Patient. 2012;5(1):57-69. doi: 10.2165/11592160-000000000-00000.

PMID:
22217263
12.

Health status and costs of ambulatory patients with multiple sclerosis in Hungary.

Péntek M, Gulácsi L, Rózsa C, Simó M, Iljicsov A, Komoly S, Brodszky V.

Ideggyogy Sz. 2012 Sep 30;65(9-10):316-24.

PMID:
23126217
13.

Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada.

Karampampa K, Gustavsson A, Miltenburger C, Kindundu CM, Selchen DH.

J Popul Ther Clin Pharmacol. 2012;19(1):e11-25. Epub 2012 Jan 10.

14.

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability.

Casado V, Martínez-Yélamos S, Martínez-Yélamos A, Carmona O, Alonso L, Romero L, Moral E, Gubieras L, Arbizu T.

BMC Health Serv Res. 2006 Nov 1;6:143.

15.

[Health care costs of multiple sclerosis in Austria. Cross-sectional study including consideration of quality of life].

Ganzinger U, Badelt C, Vass K, Strasser-Fuchs S, Fazekas F, Berger T, Dahlke F.

Nervenarzt. 2004 Oct;75(10):1000-6. German.

PMID:
15150646
16.

Costs and quality of life of patients with multiple sclerosis in Europe.

Kobelt G, Berg J, Lindgren P, Fredrikson S, Jönsson B.

J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):918-26. Epub 2006 May 11.

17.

Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis.

Rotstein Z, Hazan R, Barak Y, Achiron A.

Autoimmun Rev. 2006 Oct;5(8):511-6. Epub 2006 Mar 10. Review.

PMID:
17027884
18.

Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands.

Karampampa K, Gustavsson A, van Munster ET, Hupperts RM, Sanders EA, Mostert J, Sinnige OL, de Graaf J, Pop P, Miltenburger C, Groot MT, Relleke M, van der Hel WS.

J Med Econ. 2013 Jul;16(7):939-50. doi: 10.3111/13696998.2013.807267. Epub 2013 Jun 12.

PMID:
23692584
19.

Costs and disability among stroke patients.

Kavanagh S, Knapp M, Patel A.

J Public Health Med. 1999 Dec;21(4):385-94.

20.

Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life.

Parkin D, Jacoby A, McNamee P, Miller P, Thomas S, Bates D.

J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):144-9.

Items per page

Supplemental Content

Write to the Help Desk